Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Mouse hair follicle stem cells lose their ability to change into different cell types after being grown for a long time.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Human hair follicle cells can be successfully transformed into different types of cells, but not more efficiently than other adult cells.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

KLF4 is important for maintaining skin stem cells and helps heal wounds.

Antiandrogen therapy helps treat genetic hair loss.

Lower melatonin levels are linked to more skin aging.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.